KAEX is a patent pending nutraceutical / otc pharmaceutical
Kaex has raised $3.5M in total funding. The most recent round was Undisclosed. The last funding was announced in October 2026.
Kaex's investors include Belinda Bencic, Crowdcube, mediaforgrowth, SevenAccelerator, Artemon Capital.
Kaex is headquartered in Zürich, Switzerland.
KAEX is a patent pending nutraceutical / otc pharmaceutical
Kaex is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kaex — Funding & Investors." VCBacked, October 15, 2026, https://www.vcbacked.co/company/kaex. Accessed November 12, 2026.
VCBacked. (2026). Kaex — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/kaex
{{cite web |title=Kaex — Funding & Investors |url=https://www.vcbacked.co/company/kaex |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Kaex? Request a listing update